This morning Origin Pharma Packaging was announced as a shortlisted finalist at the CPhI Pharma Awards. Hybrid Pharma Packaging (HP3) was submitted as an innovative packaging supply chain model, which increases speed to market and reduces cost from concept, to delivery to the pharma filling site.

Origin Pharma Packaging's Head of Marketing, Rich Quelch explains how proud the company are in being recognised for HP3 as an innovative pharma packaging supply chain:

"We are genuinely ecstatic to be announced as one of the four finalists for the CPhI Pharma Awards. HP3 is revolutionising the pharma packaging supply chain, with global clients approaching Origin to look after their packaging design, through to delivering the final packaging product at their specifically selected global filling sites."

HP3 consists of three elements:

Design & Innovation
Strategic Manufacturing
Supply Chain Consolidation

Rich Quelch goes onto explain the development phase of the model and how it is benefiting pharmaceutical companies across the globe:

"Origin undertook a huge research programme to establish strategic manufacturing sites across the globe. These findings led to a significant investment programme selecting strategic manufacturing cells, with specific and various production techniques.

We now have global pharma clients contacting us to manage their whole packaging supply chain from design through to delivery at their filling site - an exciting model, which is delivering results."

The CPhI Pharma Awards Gala will take place on Tuesday 4th October at Fairmont Rey Juan Carlos I, where the finalists, judges, industry decision makers and influencers, press and partners will gather to celebrate the best in pharma. Congratulations to all companies that entered CPhI Pharma Awards and good luck to the finalists.